Latest Press Releases

Oct 23, 2018, 08:45 ET

Kibow Biotech’s “Enteric Dialysis®” Technology and Its Renadyl™ Product Formulation for Maintaining Healthy Kidney Function Is to Showcase Its Ultimate Validation at the Annual ASN 2017 – Kidney Week Conference.

Kibow Biotech is proud to announce its 21st year of operations as a pioneer with the use of Pro/Prebiotics in people with failing kidneys. Kibow has been participating and exhibiting at the annual meeting of the American Society of Nephrology being held from Oct 22–28, San Diego, CA.

          Read More →

Jun 04, 2018, 08:47 ET

Kibow Biotech to Present Its Breakthrough and Proven “Enteric Dialysis®” Technology at BIO 2018 International Convention, June 4-7 in Boston, MA, USA (www.BIO.org).  This annual convention is the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

          Read More →

May 04, 2018, 08:15 ET

Kibow Biotech to Participate in The Pediatric Academic Societies (PAS) 2018 Meeting, May 5-8, 2018 in Toronto, Canada , (https://www.pas-meeting.org/ ) where it will introduce its plan to develop clinical studies for pediatric CKD patients using its innovative dietary supplement product, Renadyl™, the first and only kidney health supplement formulated and developed with pharmaceutical like validation, which utilizes revolutionary “Enteric Dialysis®” technology.

          Read More →

Mar 08, 2018, 12:53 ET

On World Kidney Day Centaur Pharmaceuticals & Kibow Biotech, USA, Announce a Strategic Alliance to Market Renadyl in India for Chronic Kidney Illness

– Prevalence of Chronic Kidney Illness in India is 17.2% and rising[1].

– Dialysis is a painful and expensive process with scarcely available resources.

– This novel, US-patented, and clinically-tested product helps maintain healthy kidney functions.

          Read More →

Feb 28, 2018, 08:45 ET

Kibow® Fortis Recently Featured at the 2018 Integrative Healthcare Symposium in New York, NY. Kibow Biotech, the 20-year-old Research & Development Company and creator of the World’s first probiotic kidney health supplement Renadyl™, are announcing the availability of Kibow Fortis® a premium multi-fiber prebiotic supplement. Kibow Fortis, the world’s most comprehensive multi-fiber supplement is comprised of 6 prebiotic fibers. Other fiber supplements primarily use only psyllium husk and methylcellulose; these fibers alone can’t work as well as Kibow Fortis. The product was recently featured at the 2018 Integrative Healthcare Symposium in New York, New York. Recently, healthcare practitioners have expressed serious interest in the prebiotic multi-fiber formulation for its ability to promote the formation of high amounts of Short Chain Fatty Acids (SCFAs), specifically the formation of propionate and butyrate. SCFAs have been studied for their importance in regulating the immune system, strengthening the epithelial lining. Decades of research by Kibow’s leading team of microbiome scientists have allowed Kibow Biotech to formulate Kibow Fortis with science in mind.

          Read More →

Nov 20, 2017, 07:15 ET

Global $10 Billion Probiotics Dietary Supplement Market 2017-2022 – Key Players are DowDuPont, Chr. Hansen Holding A/S, Royal DSM N.V., Cargill. Lifeway Foods, and KibowBiotechSome of the key players discussed in the report include DowDuPont, Chr. Hansen Holding A/S, Royal DSM N.V., Cargill. Lifeway Foods, and KibowBiotech among others. New product launch owing to continuous R&D and industry integrations are the major strategies being adopted by players to differentiate

Read More →

Oct 31, 2017, 08:35 ET

Kibow Biotech’s “Enteric Dialysis®” Technology and Its Renadyl™ Product Formulation for Maintaining Healthy Kidney Function Is to Showcase Its Ultimate Validation at the Annual ASN 2017 – Kidney Week Conference.

Kibow Biotech is proud to announce its twentieth year of operations as a leader in the kidney health supplement marketplace. For the past 13 years, Kibow has been participating and exhibiting at the annual meeting of the American Society of Nephrology: Kidney Week event (https://www.asn-online.org/kidneyweek/) educating nephrology professionals on the crucial role of the gut-kidney connection, dysbiosis, and modulation of the Gut Microbiome with its innovative “Enteric Dialysis®” technology.

Read More →

Oct 24, 2017, 08:40 ET

Revolutionary, Non-Invasive, Cost Effective Renal Technology Working 24/7 Shows It Helps Maintain Healthy Kidney Function

For 20 years, Kibow Biotech has been refining a novel approach to maintaining healthy kidney function “Enteric Dialysis®”. Enteric Dialysis® utilizes probiotics (yes, probiotics) to metabolize the waste products (toxins) building up in the bloodstream due to reduced kidney function. Kibow Biotech will be exhibiting for the 13th consecutive year at the annual American Society of Nephrology conference in New Orleans, Louisiana

Read More →

Oct 11, 2017, 08:45 ET

Kibow Biotech Celebrates 20 Years of Operations With Further Validation of Its “Enteric Dialysis®” Technology, and Renadyl™ Product Formulation for Maintaining Healthy Kidney Function

Kibow Biotech is proud to announce its twentieth year of operations as a leader in the kidney health supplement marketplace. Nine out of 10 biotech companies fail within the first five years of business; Kibow has managed to stay on the cutting edge of science with its product Renadyl™ based on “Enteric Dialysis®” technology. Renadyl™ is the first and only kidney health supplement formulated to maintain healthy kidney function.

Read More →

Jun 20, 2017, 08:35 ET

Kibow Biotech Inc. (Buzz of Bio Winner, 2014) Receives US Patent for Gout/Hyperuricemia Product Formulation Based on Modulation of the Gut Microbiome With Probiotics and Prebiotics

Kibow Biotech Inc., a pioneer in developing “Enteric Dialysis®” technology, is pleased to                         announce the issuance of a new patent covering a unique method for preventing or treating gout           or hyperuricemia by the U.S. Patent and Trademark Office on May 23rd 2017.

Read More →

Mar 09, 2017, 08:35 ET

Kibow Biotech Inc. to Support the World Kidney Day (March 9th) With an Independent Educational Webinar on “Obesity and Chronic Kidney Disease” and Modulating the “Gut Microbiome With Pro/Prebiotics” Based on Its Novel “Enteric Dialysis®” Technology Formulation

Read More

Nov 15, 2016, 08:40 ET

Kibow Biotech Further Validates RENADYL™ Towards Failing Kidney Function and its Original Concept Kibow Biotech Further Validates RENADYL™ Towards Failing Kidney Function and its Original Concept “Will the Bowel be the Kidney of Future?” With Greater Understanding and Recognition in the #1 Emerging Field of Microbiome

Read More →

Nov 12, 2015, 08:45 ET

Kibow Biotech Continues to Document the “Enteric Dialysis™” Concept With Its Patented Product RENADYL™ Towards Modulation of the Gut Microbiome (GUT-KIDNEY CONNECTION)

This year’s annual American society of Nephrology (ASN) 2015 Kidney Week conference was held at the San Diego Convention Center, Nov 3 – 8 https://www.asn-online.org/education/kidneyweek/archives/future.aspx. Kibow Biotech, Inc. was pleased to mark its 10th year of continuous…

More news about: Kibow Biotech, Inc. , American Society of Nephrology (ASN) 2015 Kidney Week

Jun 16, 2015, 08:45 ET

Kibow Biotech (A Buzz Of BIO – 2014 Winner) to Introduce the Novel Concept of “ENTERIC DIALYSIS®” With its Product Renadyl™ at the 2015 BIO International Convention in Philadelphia – June 15-18

The most prestigious and highly acclaimed annual event of the BIO-2015 is being held in Philadelphia – June 15-18.  This International Convention is hosted by the Biotechnology Industry Organization  (http://convention.bio.org/about-bio-convention/ ). Kibow Biotech, Inc. is…

More news about: Kibow Biotech

Nov 11, 2014, 08:30 ET

Kibow Biotech To Showcase Renadyl™ and Support ASN 2014 Theme For Kidney Health in Philadelphia

The American Society Of Nephrology (ASN) and more than 13,000 other kidney professionals from across the globe will be participating at Kidney Week 2014 in Philadelphia Convention Center, Pennsylvania. The world’s premier nephrology professional annual meeting, Kidney Week provides…

More news about: Kibow Biotech Inc.

Sep 22, 2014, 08:30 ET

Kibow Biotech Presents Renadyl Story about Kidney Function at Harvard Medical School Probiotics Symposium

The Harvard Medical School – Division of Nutrition will be hosting its annual symposium on probiotics on Sept 22 and 23 in Boston, MA. This symposium is intended to provide an overview of the latest scientific evidence related to gut microbiota and probiotics and their importance across the…

More news about: Kibow Biotech , Harvard Medical School , Renadyl

May 07, 2014, 08:30 ET

Pennsylvania Probiotic Dietary Supplement Company Wins Biotech Innovation Award

Kibow Biotech is delighted to be announced a winner of this year’s BIO International Convention (June 23 – 26), Buzz of BIO Contest. The Pennsylvania based company is one of the four winners in this year’s contest recognizing the most innovative companies in the biotech sector. …

More news about: Kibow Biotech

Apr 15, 2014, 08:30 ET

Kibow Biotech of Newtown Square, Pennsylvania — First Dietary Supplement Company, Nominated to Participate in the “Buzz of BIO”- Pipelines of Promise Category at the 2014 BIO International Convention.

Kibow Biotech is pleased to participate in the Buzz of BIO for the 2014 BIO International Convention. Hosted by the Biotechnology Industry Organization (BIO), this year’s global event for biotechnology will take place June 23-26, 2014 at the San Diego Convention Center in California. During the…

More news about: Kibow Biotech

Mar 14, 2014, 08:45 ET

Kibow Biotech Joins with Apollo Hospital Group to Celebrate Dr. Eli Friedman and His Contribution to the Field of Nephrology with Lifetime Achievement Award

Kibow Biotech is pleased to announce that March 13, on the occasion of World Kidney Day (worldkidneyday.org), it joined with Apollo Hospital Group (Chennai, India) to honor Dr. Eli A. Friedman, M.D., M.A.C.P., F.A.C.P., with a Lifetime Achievement Award, celebrating his excellence and…

More news about: Kibow Biotech, Inc.

Mar 13, 2014, 08:35 ET

Kibow Biotech Marks World Kidney Day with Introduction of Renadyl™ Product to India Market

Kibow Biotech is pleased to announce that it will mark World Kidney Day (March 13, worldkidneyday.org) with the launch of Renadyl™, its patented, clinically validated probiotic dietary supplement for kidney health, in India. This milestone event will coincide with Kibow’s participation…

More news about: Kibow Biotech, Inc.